The MM+M Podcast is Medical Marketing + Media’s show about healthcare marketing writ large. Each week, hosts Marc Iskowitz and Larry Dobrow — senior editors at the publication — interview the executives commercializing brands, the agencies supporting launches, and other fascinating guests from in and around the industries of pharma, biotech, med-tech ad-tech and health media.
Bayer puts its global oncology team on display
Bayer’s Emma Fountain, VP of research and development projects and a breast cancer survivor, explains how the Inspired By You global campaign has raised cancer consciousness at the company.
Clinical lab industry faces a new test
Mayo Clinic Labs’ Dr. Bill Morice, who’s also board chair for the American Clinical Lab Association, describes the marketing challenge of demonstrating the value of the lab for healthcare.
Why pharma branded work didn’t make the Cannes cut
Collette Douaihy, 2024 Cannes Lions Pharma jury president, explains the dearth of award-caliber, regulated pharma work from this year’s program. Plus, a review of recent SCOTUS decisions impacting healthcare.
How AI may give pharma brands a human touch
Elaine Gamble explains how AI may facilitate pharma brands’ social-care strategy.
Live from Cannes: MM+M’s Steve Madden offers takeaways on Health Lions
MM+M’s Steve Madden interviews Cannes Lions Health 2024 honorees and attendees in the French Riviera.
2024 MM+M Women of Distinction preview: A case for female-led med research
MM+M’s 2024 Women of Distinction keynote, Carolee Lee, CEO/founder of Women’s Health Access Matters, makes an economic case for women-focused medical research.
2024 MM+M Agency 100 preview: Breaking down medical marketing X’s and O’s
On this week’s show, devoted entirely to previewing the 2024 MM+M Agency 100 issue, MM+M’s Larry Dobrow explains the uniqueness of this year’s edition.
The first draft of health-AI ethics rules
Dr. Brian Anderson, CEO/co-founder of CHAI, reports on the group’s progress in readying a first draft of ethics rules for use of AI in healthcare.
Inside Takeda’s stake in ‘food as medicine’
Takeda’s Chris Barr explains why the drugmaker’s multi-million-dollar CSR program includes a big stake in the “food as medicine” approach.
Go-to pharma CX framework with Harmony Biosciences’ Joyce Ercolino
Harmony Biosciences’ Joyce Ercolino shares her go-to pharma customer experience framework.
PSA urges parents to just ask Gen Zers about suicide
The marketers behind a new PSA explain why it urges Gen X parents to just ask their Gen Z kids about suicide.
The Biden administration punts on menthol cigarette ban. What comes next?
Brian Quigley, CEO of Qnovia, unpacks the implications of the Biden administration’s decision to delay a ban on menthol cigarettes.
Supernus casts Busy Philipps as lead in Qelbree ADHD campaign
Rebecca Lannan, executive marketing director at Supernus Pharmaceuticals, discusses the brand’s Qelbree campaign featuring actress Busy Philipps.
2024 MM+M Pinnacle preview: How Begasse and Pantello reached the apex
Set to be honored at the 2024 MM+M Pinnacle Awards this Thursday, Ken Begasse, Jr., and Tim Pantello share their distinct career paths.
Currax Pharmaceuticals CEO says the GLP-1 conversation isn’t one-size-fits-all
Currax Pharmaceuticals CEO George Hampton talks about the ascendance of GLP-1 drugs and how weight loss drugs are changing the obesity narrative.
4/20 focus: Why cannabis may be close to shedding its outlaw past
David Traylor of investment bank Golden Eagle Partners discusses the state of cannabis regulation. Plus, our Policy and Trends segments.
How Perrigo’s OTC birth control Opill partnered with the WNBA
Leila Bahbah, Perrigo U.S. Women’s Health Brand Lead, talks about how birth control medication Opill partnered with the WNBA.
Can NewYork-Presbyterian become a lifestyle brand?
NewYork-Presbyterian’s Devika Mathrani explains how the hospital system is rethinking its marketing to become more like a lifestyle brand.
Former NBA All Star Jamal Mashburn helms Exact Sciences’ colon cancer push
Former NBA All Star and Kentucky Wildcats legend Jamal Mashburn discusses his participation in Exact Sciences’ Box Out Colon Cancer campaign.
MM+M Transform 2024 preview: Northwell’s Ramon Soto and Lilly’s Derek Asay
On the eve of the 2024 MM+M Transform conference, Northwell Health’s Ramon Soto and Eli Lilly’s Derek Asay offer an advanced look at topics to be discussed at their sessions.
